Advances in the use of stem cells and tissue engineering applications in bone repair

Current Stem Cell Research and Therapy

Volumn 7, Issue 2, 2012, Pages 122-126

  Chimutengwende Gordon, Mukai ^a   Khan, Wasim S ^b  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bone; Clinical studies; Preclinical studies; Scaffolds; Stem cells; Tissue engineering

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN; HYDROXYAPATITE; POLYANHYDRIDE; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TISSUE SCAFFOLD; VIRUS VECTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOCOMPATIBILITY; BIOREACTOR; BONE CONDUCTION; BONE REMODELING; CELL DIFFERENTIATION; CELL RENEWAL; EMBRYONIC STEM CELL; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; IMMUNOGENICITY; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL TRANSPLANTATION; TIBIA SHAFT FRACTURE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; XENOGRAFT;

BONE REGENERATION; FRACTURES, BONE; HUMANS; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING;

EID: 84857711477     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488812799219036     Document Type: Review

References (50)

1. Braddock M, Houston P, Campbell C, Ashcroft P. Born again bone: tissue engineering for bone repair. News Physiol Sci 2001; 16: 208-13.
2. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998; (355 Suppl): S7-21.
3. Arvidson K, Abdallah BM, Applegate LA, et al. Bone regeneration and stem cells. J Cell Mol Med 2011; 15(4): 718-46.
4. Fröhlich M, Grayson WL, Marolt D, Gimble JM, Kregar-Velikonja N, Vunjak-Novakovic G. Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng Part A 2010; 16: 179-89.
5. Marolt D, Knezevic M, Novakovik V. Bone tissue engineering with human stem cells. Stem Cell Research & Therapy 2010; 1: 10.
6. Khan WS, Marsh D. Tissue Engineering Approaches for Bone Repair: Cells, Scaffolds, Growth Factors and Gene Therapy. Stem Cell Research Journal 2010; 2: 21-32.
7. Kruyt MC, van Gaalen SM, Oner FC, Verbout AJ, de Bruijn JD, Dhert WJ. Bone tissue engineering and spinal fusion: the potential of hybrid constructs by combining osteoprogenitor cells and scaffolds. Biomaterials 2004; 25: 1463-73.
8. Chao PH, Grayson W, Vunjak-Novakovic G. Engineering cartilage and bone using human mesenchymal stem cells. J Orthop Sci 2007; 12: 398-404.
9. Naujoks C, Berr K, Meyer U. Laboratory Procedures: Culture of Cells and Tissues. In: Fundamentals of Tissue Engineering and Regenerative Medicine. Springer-Verlag Berlin Heidelberg 2009; 559-564.
10. Handschel J, Kübler N. Cell Sources for Bone Reconstruction Therapies. European Musculoskeletal Review 2006; 71-3.
11. Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL. Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A 2009; 15: 1897-907.
12. Seong JM, Kim BC, Park JH, Kwon IK, Mantalaris A, Hwang YS. Stem cells in bone tissue engineering. Biomed Mater 2010; 5: 062001.
13. Jukes JM, Both SK, Leusink A, Sterk LM, van Blitterswijk CA, de Boer J. Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci USA 2008; 105: 6840-5.
14. Karp JM, Ferreira LS, Khademhosseini A, Kwon AH, Yeh J, Langer RS. Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells 2006; 24: 835-43.
15. Hu J, Liu X, Ma PX. Biomineralization and Bone Regeneration. In: Principles of Regenerative Medicine. Academic Press (Elsevier) 2008: 744-56.
16. Cao T, Heng BC, Ye CP, et al. Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of morphologically distinct nodule-like structures. Tissue Cell 2005: 37: 325-34.
17. Heng BC, Cao T, Stanton LW, Robson P, Olsen B. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res 2004; 19: 1379-94.
18. Grinnemo KH, Sylvén C, Hovatta O, Dellgren G, Corbascio M. Immunogenicity of human embryonic stem cells. Cell Tissue Res 2008; 331: 67-78.
19. Muschler GF, Nakamoto C, Griffith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 2004; 86-A: 1541-58.
20. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
21. Cancedda R, Bianchi G, Derubeis A, Quarto R. Cell therapy for bone disease: a review of current status. Stem Cells 2003; 21: 610-9.
22. Meijer GJ, de Bruijn JD, Koole R, van BLitterswijk CA. Cell-based bone tissue engineering. PLoS Med 2007; 4(2): e9.
23. Kadiyala S, Jaiswal N, Bruder SP. Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a criticalsized segmental bone defect. Tissue Eng 1997; 3: 173-85
24. Tseng SS, Lee MA, Reddi AH. Nonunions and the potential of stem cells in fracture healing. J Bone Joint Surg Am 2008; 90: 92-8.
25. Yoon E, Dhar S, Chun DE, Gharibjanian NA, Evans GRD. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007; 13:619-27.
26. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998; 80: 985-96.
27. Kon E, Muraglia A, Corsi A, et al. Autologus bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 2000; 49: 328-37.
28. Kruyt MC, Dhert WJ, Yuan H, et al. Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res 2004; 22: 544-51.
29. Grayson WL, Fröhlich M, Yeager K, et al. Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci USA 2010; 107: 3299-304.
30. Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M, Khoshzaban A, Ahmadbeigi N. Sinus augmentation using human mesenchymal stem cells loaded into a β -tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 203-9.
31. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344: 385-6.
32. Khan Y, Yaszemski MJ, Mikos AG, Laurencin CT. Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am 2008; 90 Suppl 1: 36-42.
33. Sachlos E, Czernuszka JT. Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater 2003; 5: 29-39.
34. Tognana E, Borrione A, De Luca C, Pavesio A. Hyalograft C: hyaluronan-based scaffolds in tissue-engineered cartilage. Cells Tissues Organs 2007; 186: 97-103.
35. Schieker M, Seitz H, Drosse I, Seitz S, Mutschler W. Biomaterials as Scaffold for Bone Tissue Engineering. Eur J Trauma 2006; 2: 114-24.
36. Idris S, Arvidson K, Plikk P, et al. Polyester copolymer scaffolds enhance expression of bone markers in osteoblast-like cells. J Biomed Mater Res A 2010; 94: 631-9.
37. Guarino V, Causa F, Netti PA, et al. The role of hydroxyapatite as solid signal on performance of PCL porous scaffolds for bone tissue regeneration. J Biomed Mater Res Part B: Appl Bomater 2008; 86: 548-57.
38. Meinel L, Karageorgiou V, Fajardo R, et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 2004; 32: 112-22.
39. Grayson WL, Bhumiratana S, Cannizzaro C, et al. Effects of initial seeding density and fluid perfusion rate on formation of tissueengineered bone. Tissue Eng Part A 2008; 14: 1809-20.
40. Oragui E, Nannaparaju M, Khan WS. The role of bioreactors in tissue engineering for musculoskeletal applications. Open Orthop J 2011; 5 Suppl 2: 267-70.
41. Boden SD. Bioactive factors for bone tissue engineering. Clin Orthop Relat Res 1999; (367 Suppl): S84-94.
42. Zdeblick TA, Ghanayem AJ, Rapoff AJ, et al. Cervical interbody fusion cages. An animal model with and without bone morphogenetic protein. Spine (Phila Pa 1976) 1998; 23: 758-65.
43. Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 1998; 11: 95-101.
44. Magin MN, Delling G. Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep. Spine (Phila Pa 1976) 2001; 26: 469-78.
45. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) 1995; 20: 1326-37.
46. Sandhu HS, Kanim LE, Toth JM, et al. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine (Phila Pa 1976) 1997; 22: 1171-80.
47. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002; 84-A: 2123-34.
48. Alt V, Donell ST, Chhabra A, Bentley A, Eicher A, Schnettler R. A health economic analysis of the use of rhBMP-2 in Gustilo- Anderson grade III open tibial fractures for the UK, Germany, and France. Injury 2009; 40: 1269-75.
49. Tai K, Pelled G, Sheyn D, et al. Nanobiomechanics of repair bone regenerated by genetically modified mesenchymal stem cells. Tissue Eng Part A 2008; 14: 1709-20.
50. Gao X, Kim KS, Liu D, et al. Nonviral gene delivery: what we know and what is next. AAPS J 2007; 9: E92-104.